Advertisement
Advertisement
NRXS
Neuraxis, Inc.
8.20
USDSponsored
-0.60
-6.82%
May 08, 15:58 UTC -4
Closed
After-Market
8.62
+0.42
+5.12%
NRXS Earnings Reports
Positive Surprise Ratio
NRXS beat 2 of 8 last estimates.
25%
Next Report
In 2 Days
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.48M
/-$0.19
Implied change from Q4 25 (Revenue/ EPS)
+52.77%
/+11.76%
Implied change from Q1 25 (Revenue/ EPS)
+65.07%
/-42.42%
Neuraxis, Inc. earnings per share and revenue
On Mar 19, 2026, NRXS reported earnings of -0.17 USD per share (EPS) for Q4 25, beating the estimate of -0.21 USD, resulting in a 22.48% surprise. Revenue reached 968.13 thousand, compared to an expected 867.00 thousand, with a 11.66% difference. The market reacted with a +2.43% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.19 USD, with revenue projected to reach 1.48 million USD, implying an increase of 11.76% EPS, and increase of 52.77% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
May 07, 2026 For Q1 26
Estimate
$0.83
Actual
$0.89
Surprise
+6.65%
Clover Health Investments, Corp
Report Date
May 06, 2026 For Q1 26
Estimate
$0.03
Actual
$0.07
Surprise
+128.76%
Claritev Corporation
Report Date
May 07, 2026 For Q1 26
Estimate
-$4.08
Actual
-$4.41
Surprise
-7.90%
Evolent Health, Inc Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.02
Surprise
+61.39%
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.02
Surprise
+1.96%
CareCloud, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.05
Surprise
+835.29%
American Well Corporation
Report Date
May 05, 2026 For Q1 26
Estimate
-$1.18
Actual
-$0.78
Surprise
+33.98%
Outset Medical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.81
Actual
-$0.83
Surprise
-2.00%
10x Genomics, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.10
Surprise
+66.04%
Privia Health Group, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.07
Actual
$0.02
Surprise
-73.72%
FAQ
What were Neuraxis, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Neuraxis, Inc. reported EPS of -$0.17, beating estimates by 22.48%, and revenue of $968.13K, 11.66% above expectations.
How did the market react to Neuraxis, Inc.'s Q4 2025 earnings?
The stock price moved up 2.43%, changed from $6.99 before the earnings release to $7.16 the day after.
When is Neuraxis, Inc. expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Neuraxis, Inc.'s next earnings report?
Based on 3
analysts, Neuraxis, Inc. is expected to report EPS of -$0.19 and revenue of $1.48M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement